Merus Labs International (Merus Labs International) COGS-to-Revenue : 0.37 (As of Mar. 2017)

View and export this data going back to 1996. Start your Free Trial

What is Merus Labs International COGS-to-Revenue?

Merus Labs International's Cost of Goods Sold for the three months ended in Mar. 2017 was $6.29 Mil. Its Revenue for the three months ended in Mar. 2017 was $16.92 Mil.

Merus Labs International's COGS to Revenue for the three months ended in Mar. 2017 was 0.37.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Merus Labs International's Gross Margin % for the three months ended in Mar. 2017 was 62.80%.

Merus Labs International COGS-to-Revenue Historical Data

The historical data trend for Merus Labs International's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merus Labs International COGS-to-Revenue Chart

Merus Labs International Annual Data

Trend

Sep07

Sep08

Sep09

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

COGS-to-Revenue

Get a 7-Day Free Trial

0.09

0.17

0.15

0.33

Merus Labs International Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
COGS-to-Revenue	Get a 7-Day Free Trial															0.31	0.34	0.36	0.31	0.37

Merus Labs International COGS-to-Revenue Calculation

Merus Labs International's COGS to Revenue for the fiscal year that ended in Sep. 2016 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	22.839	/	69.481
	=	0.33

Merus Labs International's COGS to Revenue for the quarter that ended in Mar. 2017 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	6.294	/	16.918
	=	0.37

Merus Labs International (NAS:MSLI) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Merus Labs International's Gross Margin % for the three months ended in Mar. 2017 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	6.294 / 16.918
	=	62.80 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Merus Labs International COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Merus Labs International's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Merus Labs International (Merus Labs International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merus Labs International Inc (NAS:MSLI) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.meruslabs.com

Merus Labs International Inc was incorporated on October 1, 2012 in British Columbia. The Company is a specialty pharmaceutical company. It acquires prescription medicines in various categories which include on patent but at maturity stage of product life cycle; branded generics; under promoted products; Niche market pharmaceuticals; and products with annual sales below critical threshold for large pharma. The Company competes with multinational pharmaceutical development corporations to small, single product companies that may limit their activities to a particular therapeutic area or region or territory.

Merus Labs International (Merus Labs International) Headlines

From GuruFocus

Update on Merus Labs International, Athabasca Minerals Inc, Enghouse Systems Limited, WiLAN Inc.

By Gordon Pape Gordon Pape • 06-22-2015

Merus Labs International: A Pharma Stock With Growth Potential

By Gordon Pape Gordon Pape • 03-30-2015

Slow Growth Ahead; Updates on Merus Labs International, Enghouse Systems, Athabasca Minerals

By Gordon Pape Gordon Pape • 10-05-2015